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Abstract
Background: The care needs of patients with a limited prognosis (<12 months median) are complex and dynamic.
Patients and caregivers must cope with many challenges, including physical symptoms and disabilities, uncertainty.
and compromised self-efficacy. Healthcare is often characterized by disruptions in the transition between healthcare
providers. The Milestones Communication Approach (MCA) is a structured, proactive, interprofessional concept that
involves physicians and nurses and is aimed at providing coherent care across the disease trajectory. This study
aims to evaluate these aspects of MCA: (1) the training of healthcare professionals, (2) implementation context and
outcomes, (3) patient outcomes, and (4) effects on interprofessional collaboration.
Methods/design: A multiphase mixed-methods design will be used for the study. A total of 100 patients and 120
healthcare professionals in a specialized oncology hospital will be involved. The training outcomes will be documented
using a questionnaire. Implementation context and outcomes will be explored through semi-structured interviews and
written questionnaires with healthcare professionals and with the training participants and through a content analysis
of patient files. Patient outcomes will be assessed in a pragmatic non-blinded randomized controlled trial and in
qualitative interviews with patients and caregivers. Trial outcomes are supportive care needs (SCNS-SF34-G), quality of
life (SeiQol and Fact-L), depression and anxiety symptoms (PHQ-4), and distress (Distress Thermometer). Qualitative
semi-structured interviews on patients’ views will focus on shared decision-making, communication needs, feeling
empathy, and further utilization of healthcare services. Interprofessional collaboration will be explored using the UWE-
IP-D before the implementation of MCA (t0) and after 3 (t1), 9 (t2), and 12 (t3) months.
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Discussion: Using guideline-concordant early palliative care, MCA aims to foster patient-centered communication with
shared decision-making and facilitation of advance care planning including end-of-life decisions, thus increasing
patient quality of life and decreasing aggressive medical care at the end of life. It is assumed that the communication
skills training and interprofessional coaching will improve the communication behavior of healthcare providers and
influence team communications and team processes.
Trial registration: German Clinical Trials Register, DRKS00013649 and DRKS00013469. Registered on 22
December 2017.
Keywords: Communication, Prognosis, Interprofessional relations, Complex intervention, Multiphase mixed
method, Implementation, Palliative care, Prognostic awareness, Randomized controlled trial
Background
The care of patients with a limited prognosis is complex
and demanding. Moreover, the process of care is often
interrupted by quick transitions between healthcare set-
tings and providers, especially for cancer patients [1], lead-
ing to a lack of continuity in care. Throughout the disease
trajectory, patients and caregivers must deal with receiving
bad news at short intervals. The terminal character of a
limited prognosis means that patients need to engage in
advance care planning and end-of-life decision-making.
Therefore, patients and their caregivers must deal with
several dimensions of burden (physical, psychological, so-
cial, financial, and spiritual) [2].
The quality of care for patients with advanced cancer
hinges, among other factors, on the communication
skills of the healthcare professionals involved. Delivering
bad news, discussing prognoses and possible disease tra-
jectories (best case and worst case), and preparing others
for the end of life are challenging communication topics
and demand highly skilled professionals [3]. Yet, pa-
tients, caregivers, and the healthcare professionals them-
selves often perceive these skills to be insufficient [4, 5].
The German National Cancer Plan [6] and other
medical societies recommend that healthcare providers
should improve their communication skills [6–8]. In-
deed, different communication training programs have
been developed and evaluated successfully for the med-
ical curriculum [9, 10]. Yet, most of these programs
focus on basic communication skills in specific situa-
tions [11–14] without considering the whole disease
trajectory. Furthermore, communication modules con-
cerning palliative care have been developed but refer
mainly to the transition to the best supportive care for
the terminally ill [15]. The positive results of trials re-
garding the early integration of palliative care [16, 17]
additionally challenge patient–physician communica-
tions as they leave the oncologist with the task of ad-
dressing palliative care early in the course of disease.
These trials and others that evaluate the training of
communication skills in oncology have shown multiple
benefits: improvement of quality of life and advance care
planning for patients, improvement in job satisfaction,
and decrease of burden on professionals [12, 13, 18–21].
Additionally, different studies on palliative care show
that multi-professional approaches are more effective
[16, 22–24].
For advanced lung cancer, forward-thinking com-
munication has been described for the German
setting [25]. This introduces standardized steps of
communication at turning points of treatment, such
as first disclosure of diagnosis, disease progression,
and transition to best supportive care. Based on
findings from interviews with patients and caregivers
and focus groups with healthcare professionals, a
structured longitudinal concept has been developed:
the Heidelberg Milestones Communication Approach
(MCA) [5, 26, 27].
MCA is a pro-active, interprofessional concept that
involves physicians and nurses and is aimed at provid-
ing coherent care that integrates palliative care early and
across the disease trajectory. It provides intervention-based
communication to develop patient-centered care further
through increasingly integrating patient preferences. Meta-
static lung cancer has been used as a model disease in de-
veloping MCA. Not only is there a limited prognosis with a
median survival of less than 12 months but it is also associ-
ated with a substantial existential uncertainty and a high
symptom burden with detrimental impact on patients and
caregivers [27, 28]. However, institutional strategies for
implementing longitudinally structured communication
concepts such as MCA and knowledge about the effects of
implementation are still lacking.
Many interventions in clinical and health services re-
search fail to translate into practice and policy [29]. Imple-
mentation processes are complex, take a long time, and are
cost intensive [30, 31]. Therefore, the effects and imple-
mentation of an intervention need to be evaluated concur-
rently. Furthermore, implementations are influenced by
individual health, professional factors, patient factors, pro-
fessional interactions, incentives and resources, capacity for
organizational change, as well as by social, political, and
legal factors [32].
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Aims and objective
This study aims to evaluate these aspects of MCA:
1. training of healthcare professionals
2. implementation context and outcomes
3. patient outcomes
4. effects on interprofessional collaboration.
Methods/design
Multiphase mixed-methods design
Since several perspectives (patient, family caregiver, and
healthcare professional) and different interventions
(communication concept, training, and implementation)
at different stages (development, implementation, and
evaluation) are relevant, a mixed-methods design has
been chosen [33–35]. Our aims contain complex multi-
dimensional processes (social, cognitive, and cultural)
and multiple stakeholders (patients, caregivers, and
healthcare professionals). To evaluate outcomes, a ran-
domized controlled trial (RCT) and interviews with pa-
tients and caregivers are planned. To evaluate processes
and context, a combination of quantitative and qualita-
tive methods will be applied [35]. The multiphase
mixed-methods design allows a comprehensive under-
standing of the effects of MCA [34].
Phase 1: development of the Heidelberg MCA
Our previous studies in phase 1 included a qualitative
exploration of patients’ and caregivers’ experiences over
the disease trajectory and the assessment of healthcare
professionals’ views of a hypothetical structured and
forward-thinking communication approach [5, 26, 27].
Based on these results, Heidelberg MCA was developed
as a complex intervention: (a) to address the communi-
cation needs of patients and caregivers, (b) to improve
continuity of care, (c) to improve individual quality of
life of patients and their caregivers, (d) to foster shared
decision-making including end-of-life decisions, and (e)
to enhance communication competencies and team pro-
cesses of the interprofessional oncology team.
In a second step, we led in-depth interviews with
nurses and focus group interviews with physicians at our
institution to explore the enablers and barriers of imple-
mentation as well as interprofessional collaboration con-
cerning all four components of MCA. Based on the
results of these interviews, MCA was adapted and now
contains the following components (see Table 1):
1. Interprofessional (physician and nurse) communica-
tion training
2. Planned, structured nurse-physician-patient and
caregiver conversations at four points within the disease
trajectory, the so-called milestone conversations
3. Monthly follow-up sessions for outpatient and am-
bulatory patients and their caregivers (nurse)
4. Supportive materials (question-prompt-list, man-
aging symptoms guidebook for patients and caregivers,
and communication manual and memory cards for
nurses and physicians)
For a more detailed description of the intervention,
see Additional file 1.
No harm is anticipated from the intervention. If any
harm is identified, a referral to psycho-oncology services
is possible.
The complete project consists of three phases: (1) fur-
ther development, (2) implementation, and (3) evalu-
ation. Phase 1 (further development) had a separate
ethical approval (ethics committee University of Heidel-
berg S-139/2017) and is already completed. This study
protocol is for phase 2 (implementation) and phase 3
(evaluation). Implementation and evaluation are based
on the results of phase 1. During the implementation
phase, communication training will be conducted and
evaluated. Implementation of MCA will be adapted ac-
cording to participant experiences. The evaluation phase
includes a monocentric non-blinded RCT measuring the
effects of MCA in patients with a limited prognosis. In a
cohort study, the longitudinal effects on interprofes-
sional collaboration of clinical staff will be observed. Ex-
periences with the concept will be evaluated in
qualitative semi-structured interviews with patients and
their caregivers (see Table 2).
To implement MCA, it is important to understand
how MCA works within a real-life clinical setting. This
implementation implies working with healthcare profes-
sionals who will be affected by MCA and investigating
the context of the intervention. A hospital context is not
a fixed organizational structure but an unstable, unfold-
ing process [36]. Thus, implementation of MCA will be
conducted using a plan-do-check-act (PDCA) cycle [37].
– Plan: Plan communication training and a theory-
based implementation
– Do: Conduct communication training and make first
attempts at using MCA
– Check: Investigate experiences with trained nurses
and physicians
– Act: Reintegrate evaluation results into everyday
MCA practice
If necessary, the PDCA cycle will be used several
times. This approach ensures that the adaptability, us-
ability, and feasibility of MCA are incorporated [32].
Setting
The project will be conducted at the Department of
Thoracic Oncology, University Hospital Heidelberg, which
is one of the largest lung cancer centers in Germany. Every
year, about 600 patients are newly diagnosed with
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metastatic lung cancer. The physicians involved in the
project are oncologists and residents in advanced on-
cology, working mainly at the outpatient clinic. Their
daily consultations include the first disclosure of diag-
nosis and prognosis, disclosure of progression, and
transition to best supportive care (breaking bad news).
The nurses have working experience in oncology and
palliative care in both inpatient and outpatient settings.
Phase 2: implementation
Evaluation of communication training outcomes
Questionnaire for training evaluation To explore train-
ing, acceptance level 1 (reaction) and level 2 (learning) of
the Kirkpatrick model will be evaluated [38]. The sample in-
cludes five nurses and five physicians, who will receive the
training. To integrate MCA communication content, partic-
ipants will complete a self-assessment questionnaire with
26 items on acquisition of intended knowledge, skills, atti-
tude, confidence, and commitment based on participation
in the training and relevance to participants’ work. Items
are rated on a five-point Likert scale ranging from agree
completely (1), agree (2), neither agree nor disagree, dis-
agree (4) to disagree completely (5). In addition, there are
four open-ended questions on what participants liked best
or least about the training, their overall impression, and
what would help to enhance their communication skills.
Training participants (n = 10) will be invited to complete
the questionnaire after all four training sessions. The ques-
tionnaires will be analyzed using descriptive statistics, in-
cluding mean, median, standard deviation, and range.
Thematic analysis will be used to evaluate open-ended
questions [39]. The results of each training session will be
used to plan and improve the next training session.
Evaluation of implementation context and outcomes
Interviews to evaluate implementation Interviews and
focus group interviews with training participants will be
conducted between the training sessions to explore
Table 1 MCA complex intervention components
Intervention component Subcomponent Content
Communication training Two training sessions with
simulated patients and video assessment
Two training sessions in a clinical setting
including individualized feedback
Coaching
MCA conversation components
Communication skills
Attitude
Empathy
Prognostic awareness
Milestone conversations Diagnosis Breaking bad news
Treatment options
Outlining follow-up and contact
with nurse
Stable phase Question-prompt-list
Prognostic awareness
Advance care planning
Palliative care needs
Progression Question-prompt-list
Breaking bad news
Prognostic awareness
Treatment options
Advance care planning
Palliative care needs
Transition to best supportive care Question-prompt-list
Breaking bad news
Prognostic awareness
Advance care planning
Symptom treatment
Palliative care needs
Follow-up sessions Patient is contacted every month by
telephone or during a routine clinic
visit by a nurse
Palliative care assessment
Prognostic awareness
Answering patient questions
Referrals if necessary
Material Communication manual for milestone
conversations
Content of milestone conversations
Training material
Memory cards Quick overview of milestone
conversations
Managing symptoms guidebook Brochure for patients on symptom
management
Question-prompt-list Questions patients could ask
MCA Milestones Communication Approach
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participants’ experiences with and transfer of MCA into
everyday practice. A topic guide derived from the lit-
erature and our previous studies will be developed to
determine experiences and context factors that influ-
ence training, communication, implementation, and
collaboration [40]. The main issues raised in the in-
terviews will be recorded on a protocol sheet, sum-
marized, and the results fed back by the researchers
to the communication training and implementation
team [41]. The results will be used to improve the
next training sessions, to enhance implementation in
everyday practice, and to adapt both MCA materials
(communication manual, memory cards, question-
prompt-list, and brochure) and the implementation
plan following the PDCA cycle.
Quantitative content analysis of patient files From
kickoff, nurses will document excerpts from the
milestone conversations and follow-up calls in pa-
tient electronic files. Excerpts written 6 months after
kickoff (n = 50) from the milestone conversations and
(n = 50) from the follow-up calls will be analyzed for
adherence to the MCA concept, shared decision-
making, prognostic awareness, and documented
topics [41]. The file content will be analyzed using a
fidelity checklist of essential topics based on the
MCA manual. Data will be entered into SPSS and
descriptive statistics will be produced. Binary and
continuous variables will be evaluated by mean, me-
dian, minimum, and maximum, and categorical vari-
ables using absolute and relative frequencies [41].
The results will help to determine to what extent
the developers’ intentions regarding training contents
and adherence to the communication manual are
seen in practice.
Phase 3: outcome evaluation
Impact of MCA on patient outcomes
The effects of MCA on patients and caregivers will be de-
termined in a RCT. Their experiences with the concept will
be assessed in semi-structured interviews. The effects on
interprofessional collaboration will be evaluated in a longi-
tudinal observational study with healthcare professionals.
Effects on patients and caregivers (pragmatic RCT)
In the RCT, the effects of MCA on patients and care-
givers will be assessed and evaluated with a focus on
shared decision-making and on early and proactive ad-
vance care planning. Patients and their caregivers will
report on daily life activities and the identification and
treatment of palliative care needs. The impact of the
concept regarding empathy, quality of life, and distress
in patients with metastatic lung cancer will also be ex-
amined. Furthermore, needs-based use of services and
the impact of further contacts in the German healthcare
system will be assessed.
Primary outcome The primary outcome is the effect of
MCA on meeting patients’ information needs measured
using the health system and information needs dimen-
sion of the Supportive Care Needs Survey: Short Form
for Patients (German version) (SCNS-SF34-G).
Secondary outcomes The secondary outcomes are the
effects of MCA on perceived empathy, quality of life, and
distress in patients with metastatic lung cancer and a lim-
ited prognosis, needs-based use of health services, and
further contacts with healthcare professionals in the Ger-
man healthcare system.
Sample and sample size The study will consist of 100
patients and 100 caregivers named by the patients. It will
Table 2 Study aim, method, type of data, and outcome
Study aims Methods Participants Outcomes Type of
data
Phase 2
implementation
Evaluation of communication
training
Questionnaire Physicians
and nurses
Training success Quantitative
Evaluation of implementation
context and outcomes
Interview and focus group
interviews
Physicians
and nurses
Fidelity and adherence enablers and
factors associated with implementation
Qualitative
Quantitative content analysis
of patient electronic files
Adherence Quantitative
Phase 3
outcome
evaluation
Impact of MCA on patient
outcomes
Pragmatic RCT using
questionnaire
Patients and
caregivers
Supportive care needs
Patient quality of life
Patient distress
Quantitative
Semi-structured interviews Patients and
caregivers
Patient reported outcomes Qualitative
Evaluation of effects on
interprofessional
collaboration
Questionnaire Healthcare
professionals
Attitudes towards interprofessional
collaboration
Quantitative
MCA Milestones Communication Approach, RCT randomized controlled trial
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include patients with newly diagnosed metastatic lung
cancer (stage IV) who are at least 18 years old, able to
give consent, have a good knowledge of the German lan-
guage, and are willing to participate. Participating care-
givers also must be at least 18 years old, have a good
understanding of the German language, be willing to
participate, and give consent.
Data collection Recruitment of patients and caregivers
will take place at the Department of Thoracic Oncology,
University Hospital Heidelberg. Patients and caregivers
will be approached by a study nurse who works at the
department. If patients and caregivers are interested in
the project, they will receive oral and written informa-
tion about the study. After giving consent, baseline (t0)
questionnaire data will be collected before patients are
randomly assigned to a group. The first milestone con-
versation (tandem or standard communication with a
physician) will then take place. For the follow-up, ques-
tionnaires will be distributed after 3 (t1), 6 (t2), and 12
(t3) months (Fig. 1). Study plan according to SPIRIT-
checklist see Fig. 2 and Additional file 2. Patient docu-
ments will be checked by a study nurse for adverse
events. No adverse events are anticipated.
Randomization procedure The randomization into the
groups (intervention and control) will occur in the ratio
1:1. Block randomization will be performed to ensure
equal-sized groups. The randomization will be per-
formed using sealed opaque randomization envelopes,
which will be provided by the Institute of Medical Biom-
etry and Informatics Heidelberg.
Instruments All instruments are validated in German.
Table 3 provides an overview of the assessment instru-
ments. The supportive care needs of patients will be
assessed using SCNS-SF34-G. The questionnaire com-
prises 34 items and covers five domains: (1) health sys-
tem and information, (2) psychological, (3) physical and
daily living, (4) patient care and support, and (5) sexual
needs. Patients indicate on a five-point scale if and to
what degree they are in need of support (1 not applic-
able; 2 no need, satisfied; 3 low need; 4 moderate need;
or 5 high need) [42]. Subscale scores are obtained by cal-
culating the mean of scale items. The higher the sub-
scale score, the higher the need for support in the
respective domain [43].
The supportive care needs of caregivers will be measured
using the German version of the Supportive Care Needs
Survey for Partners and Caregivers (SCNS-P&C-G). The
multidimensional questionnaire consists of 45 items in four
domains: (1) healthcare service needs, (2) psychological and
emotional needs, (3) work and social needs and (4)
information needs, which are assessed on a five-point scale
(1 I have no problems, 2 I am already supported, 3 low
need, 4 moderate need, and 5 high need). Answers 1 and 2
are grouped together so that 1 stands for “there is no need
for support.” For supportive care needs domains, the mean
of the respective items will be calculated, ranging from 1 to
5 [44], and standardized on a 0–100 scale [45].
A patient’s quality of life will be assessed using the
Schedule for the Evaluation of Individual Quality of Life
(SEIQoL-Q) [46], the Functional Assessment of Chronic
Illness Therapy (basic module, FACT-G, and additional
questions on lung diseases, FACT-L) [47, 48]. The Patient
Health Questionnaire (PHQ-4) [49] will be used to assess
depression and anxiety in patients. The SEIQoL-Q mea-
sures each patient’s quality of life by choosing, rating, and
weighting five domains that patients consider important,
such as family, health, or social life/other relations [50].
The five-point scale ranges from not at all (0) to extremely
(100) important. Following this, patients must evaluate
their overall satisfaction with the areas of life on the same
scale [51].
FACT-G consists of 27 items in four domains: (1) phy-
sical well-being, (2) social well-being, (3) emotional
well-being, and (4) functional well-being. All domains, ex-
cept emotional well-being, consist of seven items, each with
a score in the range 0–28. Emotional well-being contains
six items and has a score range of 0–24. For all questions
in FACT-G, a five-point rating scale from 0 to 4 (0 not at
all, 1 a little bit, 2 somewhat, 3 quite a bit, and 4 very much)
is used. The total score for FACT-G is calculated as the
sum of the four subscale scores, provided that the overall
item response is at least 80% (i.e., at least 22 of the 27 items
were answered) and takes values between 0 and 108. Nega-
tively expressed items are reverse scored prior to summing
so that higher subscale and total scores indicate a better
quality of life [47, 48, 52]. FACT-L contains the four do-
mains of FACT-G and one lung cancer symptom-specific
subscale. The seven items of the lung cancer subscale assess
patient-reported symptoms, like shortness of breath and
loss of weight. FACT-L is also rated on a five-point
Likert-scale ranging from 0 (not at all) to 4 (very much)
with a score ranging from 0 to 28 [53].
PHQ-4 is an ultra-brief self-report questionnaire that
contains a two-item depression scale (PHQ-2) and a
two-item anxiety scale (GAD-2) [49]. Patients assess
how many times over the past 2 weeks they have felt a
loss of interest and happiness, depression, melancholy or
hopelessness, nervousness, anxiety or concern, and rest-
lessness. The ordinal-scaled answer options are not at all
(0), several days (1), more than half the day (2), and
nearly every day (3) [54]. The total score for PHQ-4
ranges from 0 to 12, with categories of psychological dis-
tress being none (0–2), mild (3–5), moderate (6–8), and
severe (9–12) [55].
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Patient distress will be measured using the NCCN
Distress Thermometer. This assessment technique was
developed by the National Comprehensive Cancer Net-
work (NCCN) and is a brief self-reported screening in-
strument for recording psycho-social stress in oncological
patients. It consists of a scale from 0 to 10 and a problem
list. A score of 5 or higher indicates that a patient is
conspicuously stressed and needs assistance [56]. If the
burden is low (0–4), no additional professional support is
required [56].
Data analysis All baseline patient characteristics will be
analyzed descriptively. Continuous variables will be
described as means with standard deviation or as me-
dians with interquartile range, minimum, and maximum.
Categorical variables will be described in absolute and
relative frequencies.
The sum of the health system and information dimension
score of SCNS-SF34-G is defined as the primary outcome
of the RCT. The primary outcome at t1 will be analyzed
using a linear model in which the outcome value is in-
cluded as dependent variable and the respective baseline
value and the treatment group as independent variables.
Missing values in the primary outcome will be replaced by
multiple imputation, which consider treatment the group
and primary outcomes at t0 as independent variables using
Fig. 1 Flow diagram for patient recruitment
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STUDY PERIOD
Enrolment Allocation Post-allocation Participant
TIMEPOINT t0 0
t1
3 
months
t2
6 
months
t3
12 
months
t4
16 
months
et
c.
Phase 2 
Implementation
ENROLMENT:
Informed consent X
INTERVENTIONS:
[Interprofessional 
Training] X
[Milestone 
conversations]
[Follow-up 
sessions]
ASSESSMENTS:
[Questionnaire for 
Training 
Evaluation]
X Training participant
[Interviews for 
Implementation 
Evaluation]
X . Trainingparticipant
[Quantitative 
content analysis of 
patient files]
X
Phase 3 
Outcome 
Evaluation
ENROLMENT:
Patient 
Caregiver
Healthcare 
professional
Eligibility screen X
Informed consent X
INTERVENTIONS:
[Milestone 
conversations]
[Follow up]
ASSESSMENTS:
Randomized 
controlled trial
X
[Supportive care 
needs]
X X X X Patient Caregiver
[Patient quality of 
life]
X X X X Patient
[Depression and 
anxiety]
X X X X Patient
[Patient distress]
X X X X Patient
ASSESSMENT:
[Semi-structured 
interviews]
X X Patient Caregiver
ASSESSMENT:
[Evaluation of 
interprofessional 
collaboration]
X X X X Healthcareprofessional
Fig. 2 Study plan
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the fully conditional specification method [57]. A complete
case analysis will be performed as an additional sensitivity
analysis. The respective parameter estimates will be re-
ported together with p values and 95% confidence intervals.
The analysis of the primary outcomes at t2 and t3 will be
done analogously to the primary linear model. The analyses
of the secondary outcomes will be performed using linear
(for continuous outcomes) or generalized linear models (for
binary outcomes). The models include the outcome value
at follow-up time t1, t2, or t3 as the dependent variable.
The respective parameter estimates will be reported along-
side descriptive p values and 95% confidence intervals. p
values smaller than 0.05 will be considered statistically sig-
nificant. Analysis will be done using the statistical software
SAS v9.4 (SAS Institute, Cary, NC).
Power calculation With a sample size of n = 100, a differ-
ence of 5 points on a scale from 0 to 100 for the primary
outcome can be shown using a two-sided t-test at a signifi-
cance level of α = 0.05 with a power of 1 – ß = 0.85, assum-
ing a standard deviation of σ = 7.4 [58]. A dropout rate of
18.5% is taken into account. Prognoses of metastatic lung
cancer and the experiences at the Department of Thoracic
Oncology, University Hospital Heidelberg have shown that
82.5% of the patients are still alive after 3 months and 75%
are still alive after 6 months. It can be assumed that the
additional variance explained by the inclusion of the base-
line value as a covariate will lead to increased power. The
sample size calculation was performed using SAS v9.4 (SAS
Institute, Cary, NC).
Effects on patients and caregivers (semi-structured
interviews)
Experiences with the MCA concept regarding empathy
and shared decision-making will be evaluated through in-
terviews with patients and caregivers.
Sample and sample size Patients and caregivers who
will experience MCA will be approached in the hospital
setting. Patients and caregivers must be over 18 years old
and able to understand and speak German well. They will
be asked to participate and receive a written invitation to
the study, including the background information, partici-
pation details, and informed consent form. About 12 pa-
tients and 12 caregivers will be interviewed, possibly
more, until data saturation is reached.
Data collection Semi-structured interviews will be con-
ducted at the Department of Thoracic Oncology, University
Hospital Heidelberg, after at least two milestone conversa-
tions have taken place. A theory-based topic guide with
open-ended questions will be used. Interviews will be digit-
ally recorded and transcribed verbatim [59].
Data analysis Interviews will be analyzed using qualitative
content analysis as described by Mayring [60]. The qualita-
tive content analysis consists of nine steps for analyzing
texts: (1) determination of the material, (2) analysis of the
original situation, (3) formal characteristics of the material,
(4) determination of the direction of the analysis, (5) theor-
etical differentiation of the question, (6) determination of
the analysis techniques and definition of the concrete
process model, (7) definition of the analysis units, (8)
analysis steps using the category system (abstract explication
and structuring) and review of the category system of theory
and material, and (9) interpretation of the results in the
direction of the question and application of content-analyt-
ical quality criteria. The Mayring concept is based on redu-
cing the initial material and is, therefore, suitable for large
amounts of data and systematic textual processing, as is the
case in this work. Although it cannot be used for an
explorative-interpretive analysis [61], the concept is well
suited to answering the questions posed in this project.
Evaluation of interprofessional collaboration
Clinical employees will assess the effects of the approach
on interprofessional collaboration and on the under-
standing of their own role within their team.
Sample and sample size All 120 team members of the
medical, nursing, administration, psycho-social and thera-
peutic professions at the Department of Thoracic Oncology,
University Hospital Heidelberg will receive oral and written
information on the MCA project with the request to par-
ticipate. Participants will then receive a written invitation to
participate in the study, including the background informa-
tion, participation details, and informed consent form.
Data collection With the invitation, participants are
asked to complete an attached questionnaire prior to the
first training within the MCA project (t0), directly after
the implementation phase (t1), and 6 (t2) and 12 (t3)
months after the implementation phase.
Table 3 Outcomes and instruments
Outcome Instrument
Supportive care needs SCNS-SF34-G (for patients) [42]
SCNS-P&C-G (for caregivers) [44]
Patient quality of life SEIQoL-Q [46]
FACT-G, FACT-L [47, 48]
Depression and anxiety PHQ-4 [47]
Patient distress Distress thermometer [56]
FACT-G Functional Assessment of Chronic Illness Therapy: general, FACT-L
Functional, Assessment of Chronic Illness Therapy: lung cancer, PHQ-4 Patient
Health Questionnaire: short form (four questions), SCNS-P&C-G Supportive Care
Needs Survey for Partners and Caregivers (German version), SCNS-SF34- G
Supportive Care Needs Survey: Short Form for Patients (German version),
SEIQoL-Q Schedule for the Evaluation of Individual Quality of Life
Siegle et al. Trials  (2018) 19:438 Page 9 of 13
Instrument The German version of the University of
the West of England Interprofessional Questionnaire
(UWE-IP-D) will be used to assess interprofessional col-
laboration and attitudes on teamwork of the healthcare
professionals [62, 63]. UWE-IP-D is a self-report instru-
ment consisting of 34 items in a set of four scales ad-
dressing different themes. It is administered at different
stages in training and education. We used three of the
four scales: communication and teamwork scale, inter-
professional interaction scale, and interprofessional rela-
tionships scale. Communication and teamwork items
will be measured on a four-point Likert scale (1 strongly
agree, 2 agree, 3 disagree, and 4 strongly disagree) lead-
ing to sum scores between 9 and 36, with scores 9–20,
21–25, and 26–36, respectively indicating a positive,
neutral, or negative self-assessment of communication
and teamwork skills. Interprofessional interaction and
interprofessional relationship items are assessed on a
five-point Likert scale (1 strongly agree, 2 agree, 3 un-
decided, 4 disagree, and 5 strongly disagree). The inter-
professional interaction scale takes sum scores between
9 and 45, with scores 9–22, 23–31, and 32–45, respect-
ively, indicating positive, neutral, and negative percep-
tions of interprofessional interaction. Sum scores on the
interprofessional relationships scale vary between 8 and
40, with scores 8–20, 21–27, and 28–40, respectively, in-
dicating positive, neutral, and negative attitudes towards
the respondent’s own interprofessional relationships.
Additionally, healthcare professionals will report gender
and profession (nursing, medical, psycho-social, therapeutic,
administrative, or other allied healthcare profession).
Data analysis All the characteristics of the healthcare
professionals will be analyzed descriptively. Categorical
variables are given as absolute and relative frequencies.
UWE-IP-D sum scores will be described as means with
standard deviation and as median with interquartile
range, minimum, and maximum. Differences between
assessments will be analyzed using repeated-measures
analysis of variance (ANOVA).
Data integration
A framework analysis will be used to integrate the data
from the quantitative and qualitative research collected
from different teams of researchers [64]. The following
steps are taken: familiarization with the material, identify-
ing a thematic framework, indexing, charting, mapping,
and interpretation [64, 65]. Emerging themes will be related
to a priori identified domains [32, 64, 65]. Findings from all
the phases will be merged using an integrative analysis [35].
Ethical aspects
Written informed consent will be obtained from each par-
ticipant. Ethical approval has been given by the Ethics
Committee of the University Hospital Heidelberg (S-561/
2017). Participants can withdraw their consent at any time.
Only investigators will have access to the final trial dataset.
There are no contractual agreements that limit such access.
Personal information and the confidentiality, coding, secur-
ity, and storage of the data are in line with German privacy
protection law (Bundesdatenschutzgesetz or BDSG) and
the privacy policy of University Hospital Heidelberg.
Discussion
In routine practice, the care of and communication with
patients with a limited prognosis is still characterized by
discontinuity and lack of coordination. Inadequate com-
munication makes coping with the realities and choices of
a complex incurable disease more difficult. A longitudinal
communication approach with a focus on the disease tra-
jectory that comprises specific milestones can serve to in-
tegrate early palliative care into routine practice and can
facilitate care that is individualized to patients’ needs and
preferences. While there are international guidelines for
advanced cancer care [3, 7], comprehensive implementa-
tion strategies are still lacking. As many structural and
organizational aspects of national healthcare systems dif-
fer substantially, any transfer of guidelines to the German
healthcare system should happen according to the specific
situation and needs in Germany.
The MCA project includes the conceptualization of a
communication strategy that focuses on a process in which
patients and their caregivers are equally involved. The im-
proved communication support should foster prognostic
awareness and therefore, facilitate advance care planning
and end-of-life decision-making.
Expected impact
The structured integrated tandem approach (physician
and nurse) with interprofessional training and coaching is
innovative. Consequently, the strengthening of interpro-
fessional collaborations can be expected. The stepwise ap-
proach of the MCA project supports the communication
skills and strategies of interprofessional healthcare teams
involved in the care of patients with a limited prognosis. It
will also enhance patients’ quality of life and improve the
continuity and coordination of care. The mixed-methods
design will provide a detailed insight into this context, in-
cluding the perspectives of professionals, patients, and
their caregivers.
Limitations and strengths
A strength of this study is that it simultaneously embeds
implementation and evaluation, using a strong design
(randomized trial) to assess outcomes. The mixed-
methods process evaluation will help in gaining a com-
prehensive understanding of what works and why. The
weaknesses of the quantitative methods are balanced by
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the qualitative methods and vice versa. This exploration of
a complex intervention is characterized by multiple
methods and multiple stakeholders in two phases. This
complexity requires a mix of researchers from different re-
search fields with experience in qualitative and quantita-
tive research. The phases of the MCA project build upon
each other. Determining the degree to which MCA is
implemented in a real-world setting will give a better un-
derstanding of the measured effects. Adaption of the inter-
ventions throughout the implementation will ensure the
practicability and transferability into everyday practice.
The sample sizes of the different investigations are
small but sufficient for an initial exploration of MCA in
a real-world setting. However, for a definitive assessment
of the effectiveness of MCA, a larger multicenter RCT is
necessary. Since the same physicians will be treating pa-
tients in the intervention arm as well as the control arm,
there is a potential for bias and cross-contamination be-
tween the trial arms. However, the nurses participating
in the milestone conversations and offering follow-up
for patients and caregivers are exclusively in the inter-
vention arm. Our primary end point is a subjective
(non-blind) patient-reported outcome, so there is a po-
tential for bias since patients know they are in a trial
and they know the purpose of the trial.
Implementing MCA and identifying relevant determi-
nants will be explored using the example of metastatic
lung cancer patients. Positive effects will be used to im-
plement an applicable version of the concept to other
medical facilities and patients with a limited prognosis.
Trial status
The beginning of recruitment for phase 2 and phase 3 is
planned for May 2018, and will be completed approxi-
mately by November 2019.
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